Lululemon’s Chip Wilson Giving Sparks Governance Debate
Chip Wilson, founder of Lululemon, remains a disruptive voice as he pushes for board changes while the company prepar...
When To Plan For Retirement
Knowing when to start your retirement planning is crucial for financial success. Explore the best times to begin your retirement journey.
19,028 articlesAnalyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Cibus (CBUS) 2025 Earnings: What Investors Should Watch
As 2025 earnings season hits, savvy investors need a clear playbook for cibus (cbus) 2025 earnings. This guide breaks...
Is the Lululemon Buy? Bull Bear Thesis After Earnings
Lululemon beat on Q4 revenue and EPS, but 2026 guidance signals slower growth and ongoing governance questions. Inves...
This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
HAUZ VNQ: This International Real Estate ETF Showdown
Considering international real estate for income? This article breaks down HAUZ and VNQ, showing how they differ, wha...
Meta’s Latest Delay Might Signal Long-Term Upside Ahead
Meta Platforms paused the public rollout of its Avocado AI model to focus on quality, while expanding its Hyperion da...
Why Intuitive Machines Stock Dropped Today: Key Insights
Investors woke up to another sharp move in a small-cap space contractor. This article breaks down why intuitive machi...
Why a $150 Million Startup Thinks It Can Solve Loneliness
A new $150 million startup thinks real world connection can counter online detachment. This report examines the plan,...
This High-Yield Lender Paying Nearly $0.50 Quarterly Has Plummeted 51%, but One Fund Just Made a Big Bet
When a trusted income vehicle slumps by half, the question isn’t just about yield—it’s about safety, value, and the b...
Forget Oral Wegovy: This Could Be a Bigger Win for Investors
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Prediction: Things That Will Shape Alibaba in 2026
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status